Page results
-
A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.
-
The National Paediatric Diabetes Audit (NPDA) is asking all children and young people (8-19 years) and parents/carers (of children under 8 years old) who have received diabetes care in the past 6 months, to fill in the survey.
-
UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.
-
A front page story and patient case study highlight SUMMIT Study early diagnosis outcomes.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
-
Having proton beam therapy: information for children aged 5-8 patient information page.
-
Having proton beam therapy: information for children aged 9-12 patient information
-
Having proton beam therapy: information for teenagers aged 13-17 patient information.
-
In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.
-
Our vaccination centre at the Business Design Centre, Islington, closed on Monday 10 January.
File results
-
FOI/2023/0550 - Varicose veins referrals, treatment and wait time
-
FOI/2023/0542 - Pulmonary rehabilitation (PR)
-
FOI/2023/0537 - Agency usage for the Occupational Therapy
-
FOI/2023/0523 - Treatment on Nivolumab
-
FOI/2023/0522 - Urology cancer pathway
-
FOI/2023/0516 - Maternity management system
-
FOI/2023/0493 - Treatments for various diseases
-
FOI/2023/0499 - Treatments for non-small cell lung cancer
-
FOI/2023/0497 - List of all laboratories within Pathology
-
FOI/2023/0500 - Treatment of urothelial and colorectal cancer